Search Results 701-710 of 13661 for Birth Control Palette

1. Study of Ociperlimab in Combination With Tislelizumab in Advanced Solid Tumors - Mayo Clinic

   PD-L1 positive. 4. ECOG Performance Status ≤ 1 5. Adequate organ function 6. Willing to use highly effective method of birth control. Phase 1 Key Exclusion ...

2. Reversing the trajectory of life - Mayo Clinic

   Mr. Ma was misdiagnosed at home and experienced a few unsuccessful treatments. His daughter brought Mr. Ma to Mayo Clinic where the patient's rare and ...

3. A Study to Evaluate the Effectiveness and Safety of Elafibranor for Patients with Nonalcoholic Fatty Liver Disease - Mayo Clinic

   Not of childbearing potential. Hysterectomy · Using efficient double contraception for the full duration of the study and for 1 month after the end of treatment.

4. Oral Pacritinib Versus Best Available Therapy to Treat Myelofibrosis With Thrombocytopenia - Mayo Clinic

   Not pregnant, not lactating, and agree to use effective birth control; Able and willing to undergo frequent MRI or CT assessments and complete symptom ...

5. A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer - Mayo Clinic

   ... controlled trial with 2:1 (regorafenib : placebo) ... Poorly-controlled ... Women must be post-menopausal infertile, or use a reliable means of contraception.

6. A Study of MK-1026 in Patients with Selected Hematologic Malignancies - Mayo Clinic

   For men and women of child-bearing potential, willing to use adequate contraception (e.g., latex condom, cervical cap, diaphragm, abstinence, etc.) for the ...

7. Obstetrics and Gynecology - Doctors - Mayo Clinic

   ... Birth control pill method, Sonohysterography, Hysterosalpingography, Endometriosis surgery, Polypectomy, Egg donation, Intracytoplasmic sperm injection ...

8. Pregnancy week by week - Mayo Clinic

   Second trimester symptoms might include larger breasts, a growing belly and skin changes. During the second trimester, the fetus begins to move and hearing ...

9. A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy - Mayo Clinic

   This is a Phase III, multicenter, randomized, placebo-controlled, double-blind study to evaluate the efficacy and safety of atezolizumab versus placebo in ...

10. Evaluation of Cu, Zn and Se levels in the North American Autism Spectrum Disorder Population - Mayo Clinic

    ... population and the diagnosis of ASD using gold standard diagnostic instruments. ... Inclusion Criteria - Healthy Controls: 24-47 months-old. Males and females.